Blue Owl Capital Co. III (OBDE) Stock Price, News & Analysis

Company Overview

Blue Owl Capital Corporation is a specialty finance company focused on lending to U.S. middle-market companies. Blue Owl Capital Corporation is based in NEW YORK.

Key Stats

• Today's Range: $14.14 to $14.14
• 50-Day Range: $14.13 to $15.29
• 52-Week Range: $13.60 to $16.80
• Volume: N/A
• Average Volume: 385,107 shs
• Market Capitalization: $1.74 billion
• P/E Ratio: 8.03
• Dividend Yield: 9.90%
• Price Target: $16.00
• Consensus Rating: Buy

Blue Owl Capital Co. III Stock Analysis - MarketRank™

Blue Owl Capital Co. III scored higher than 47% of companies evaluated by MarketBeat, and ranked 666th out of 930 stocks in the finance sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.5 / 5
• Analyst Rating: Buy

Consensus Rating

Blue Owl Capital Co. III has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

Blue Owl Capital Co. III has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: -8.81%

Earnings Growth

Earnings for Blue Owl Capital Co. III are expected to decrease by -8.81% in the coming year, from $1.59 to $1.45 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Blue Owl Capital Co. III is 8.03, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 23.65.

Price to Earnings Ratio vs. Sector

The P/E ratio of Blue Owl Capital Co. III is 8.03, which means that it is trading at a less expensive P/E ratio than the Finance sector average P/E ratio of about 24.08.

Price to Book Value per Share Ratio

Blue Owl Capital Co. III has a P/B Ratio of 0.91. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.22% of the float of Blue Owl Capital Co. III has been sold short.

Short Interest Ratio / Days to Cover

Blue Owl Capital Co. III has a short interest ratio ("days to cover") of 0.8, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Blue Owl Capital Co. III has recently increased by 833.56%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Leadership

Blue Owl Capital Co. III is a leading dividend payer. It pays a dividend yield of 9.90%, putting its dividend yield in the top 25% of dividend-paying stocks.

Dividend Growth

Blue Owl Capital Co. III does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Blue Owl Capital Co. III is 79.55%. Payout ratios above 75% are not desirable because they may not be sustainable.

Dividend Sustainability

Based on EPS estimates, Blue Owl Capital Co. III will have a dividend payout ratio of 96.55% in the coming year. This indicates that Blue Owl Capital Co. III may not be able to sustain their current dividend.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.22% of the float of Blue Owl Capital Co. III has been sold short.

Short Interest Ratio / Days to Cover

Blue Owl Capital Co. III has a short interest ratio ("days to cover") of 0.8, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Blue Owl Capital Co. III has recently increased by 833.56%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

Search Interest

Only 1 people have searched for OBDE on MarketBeat in the last 30 days. This is a decrease of -80% compared to the previous 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Blue Owl Capital Co. III insiders have not sold or bought any company stock.

Percentage Held by Insiders

90.80% of the stock of Blue Owl Capital Co. III is held by insiders. A high percentage of insider ownership can be a sign of company health.

OBDE Stock Analysis - Frequently Asked Questions

How have OBDE shares performed this year?

Blue Owl Capital Co. III's stock was trading at $14.42 at the beginning of the year. Since then, OBDE shares have decreased by 1.9% and is now trading at $14.14.
View the best growth stocks for 2025 here.

How were Blue Owl Capital Co. III's earnings last quarter?

Blue Owl Capital Co. III (NYSE:OBDE) announced its quarterly earnings results on Wednesday, November, 6th. The company reported $0.41 EPS for the quarter, beating the consensus estimate of $0.40 by $0.01. The company had revenue of $129.04 million for the quarter, compared to analysts' expectations of $122.32 million. Blue Owl Capital Co. III had a trailing twelve-month return on equity of 11.52% and a net margin of 45.35%.

Who are Blue Owl Capital Co. III's major shareholders?

Blue Owl Capital Co. III's top institutional shareholders include California State Teachers Retirement System (9.33%), Cresset Asset Management LLC (6.65%), Migdal Insurance & Financial Holdings Ltd. (5.48%) and Caz Investments LP (2.30%).
View institutional ownership trends.

How do I buy shares of Blue Owl Capital Co. III?

Shares of OBDE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Blue Owl Capital Co. III own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Blue Owl Capital Co. III investors own include Ares Capital (ARCC), Exxon Mobil (XOM), AlTi Global (ALTI), Alliance Resource Partners (ARLP), British American Tobacco (BTI), Medical Properties Trust (MPW) and Bristol-Myers Squibb (BMY).

Company Calendar

• Last Earnings: 11/06/2024
• Ex-Dividend for 12/13 Dividend: 11/29/2024
• Dividend Payable: 12/13/2024
• Ex-Dividend for 1/31 Dividend: 12/31/2024
• Dividend Payable: 1/31/2025
• Today: 2/22/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Finance
• Industry: Holding & other investment offices
• Sub-Industry: N/A
• Current Symbol: NYSE:OBDE
• Previous Symbol: NYSE:OBDE
• CUSIP: N/A
• CIK: 1807427
• Web: www.owlrockbdcs.com
• Phone: 212-419-3000
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $16.00
• High Stock Price Target: $16.00
• Low Stock Price Target: $16.00
• Potential Upside/Downside: +13.2%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Most Recent Fiscal Year): $1.76
• Trailing P/E Ratio: 8.03
• Forward P/E Ratio: 8.89
• P/E Growth: N/A
• Net Income: $271.96 million
• Net Margins: 45.35%
• Pretax Margin: 46.31%
• Return on Equity: 11.52%
• Return on Assets: 5.22%

Debt

• Debt-to-Equity Ratio: 1.28
• Current Ratio: 1.76
• Quick Ratio: 1.76

Sales & Book Value

• Annual Sales: $244.17 million
• Price / Sales: 7.14
• Cash Flow: $2.16 per share
• Price / Cash Flow: 6.54
• Book Value: $15.60 per share
• Price / Book: 0.91

Miscellaneous

• Outstanding Shares: 123,357,000
• Free Float: N/A
• Market Cap: $1.74 billion
• Optionable: N/A
• Beta: N/A